Targeting Sp1 and survivin for potential ovarian cancer therapy: Comparative assessment of anti-cancer NSAID tolfenamic acid and cisplatin Meeting Abstract

Industry Collaboration

cited authors

  • Sankpal, Umesh T., Ingersoll, Susan B., Lee, Chris M., McGann, Hasina C., Bhat, Vadiraja B., Khan, Mooez, Ahmad, Sarfraz, Holloway, Robert W., Basha, Riyaz

Publication Date

  • April 15, 2012

webpage

published in

category

volume

  • 72

WoS Citations

  • 0

WoS References

  • 0